Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

VEGFR

VEGFR are receptors for vascular endothelial growth factor and belong to receptor tyrosine kinases.

Items 31-40 of 55

Page
per page
  1. Foretinib (GSK1363089)
    A2974 Foretinib (GSK1363089)
     1 Citation
    Summary: VEGF and HGF receptor inhibitor
      ≥31.65 mg/mL
  2. Brivanib Alaninate (BMS-582664)
    A2633 Brivanib Alaninate (BMS-582664)
    Summary: VEGFR2 inhibitor,ATP-competitive
      ≥22.05 mg/mL
  3. Vatalanib (PTK787) 2HCl
    A1778 Vatalanib (PTK787) 2HCl
    Target: VEGFR
    Summary: Tyrosine kinase receptor inhibitor
      ≥21 mg/mL
  4. TSU-68 (SU6668,Orantinib)
    A5331 TSU-68 (SU6668,Orantinib)
    Summary: PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive
      insoluble in EtOH; insoluble in H2O; ≥15.5 mg/mL
  5. Ponatinib (AP24534)
    A5467 Ponatinib (AP24534)
     1 Citation
    Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src
    Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
      ≥53.3 mg/mL
  6. KRN 633
    A5760 KRN 633
    Summary: VEGFR inhibitor,ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥13.75 mg/mL
  7. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  8. Pazopanib Hydrochloride
    A8347 Pazopanib Hydrochloride
    Summary: VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor
      ≥11.1 mg/mL
  9. Axitinib (AG 013736)
    A8370 Axitinib (AG 013736)
     1 Citation
    Target: VEGFR|PDGFR|c-Kit
    Summary: VEGFR1/ c-Kit inhibitor
      insoluble in H2O; ≥19.3 mg/mL
  10. Dovitinib Dilactic acid
    A8418 Dovitinib Dilactic acid
    Summary: FLT3 inhibitor
      ≥57.3 mg/mL

Items 31-40 of 55

Page
per page